Research Paper Volume 13, Issue 23 pp 25518—25549
Identification of a novel immune signature for optimizing prognosis and treatment prediction in colorectal cancer
Figure 3. (A) Heatmap and violin plots of the NES of 10 oncogenic pathways between two subtypes in the TCGA cohort. (B) Kaplan-Meier survival curve of the high- and low- risk subgroups in GSE17538 dataset for identifying potential therapeutic agents. (C) Spearman’s correlation analysis and differential drug response analysis of 10 CTRP-derived compounds. (D) Spearman’s correlation analysis and differential drug response analysis of 10 PRISM-derived compounds. NES, normalized enrichment score.